Onconetix, Inc. SEC filings ONCO
Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 16, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Jun 2, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 11, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONCO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782107
- Former names
- Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.